Executives from Epicrispr and Metagenomi (NASDAQ:MGX) outlined next-generation gene regulation and gene-editing approaches at a Chardan discussion focused on platforms beyond conventional CRISPR gene cutting. Chardan Senior Biotech Analyst Keay Nakae said traditional CRISPR approaches use guide RNA to direct an enzyme to a DNA location, where it creates a double-stranded break. The panel examined […]